Differential regulation of ARE-mediated TNFα and IL-1β mRNA stability by lipopolysaccharide in RAW264.7 cells

Biochemical and Biophysical Research Communications

Volumn 346, Issue 1, 2006, Pages 160-168

  Chen, Yu Ling ^a   Huang, Ya Lin ^a   Lin, Nien Yi ^a   Chen, Hui Chen ^b   Chiu, Wan Chih ^a   Chang, Ching Jin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

HuR; IL 1 ; Lipopolysaccharide; TNF ; Tristetraprolin

Indexed keywords

BINDING PROTEIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL LINE; GEL MOBILITY SHIFT ASSAY; HALF LIFE TIME; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, SURFACE; BASE SEQUENCE; CELL LINE; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MICE; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR-ALPHA;

EUKARYOTA;

EID: 33745000728     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.093     Document Type: Article

References (50)

1. Guhaniyogi J., and Brewer G. Regulation of mRNA stability in mammalian cells. Gene 265 (2001) 11-23
2. Bevilacqua A., Ceriani M.C., Capaccioli S., and Nicolin A. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J. Cell. Phys. 195 (2003) 356-372
3. Chen C.Y., and Shyu A.B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20 (1995) 465-470
4. Frevel M.A., Bakheet T., Silva A.M., Hissong J.G., Khabar K.S.A., and Williams B.R.G. p38 mitogen-activated protein kinase-dependent and-independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol. Cell. Biol. 23 (2003) 425-436
5. Tebo J., Der S., Frevel M., Khabar K.S.A., Williams B.R.G., and Hamilton T.A. Heterogeneity in control of mRNA stability by AU-rich elements. J. Biol. Chem. 278 (2003) 12085-12093
6. Brennan C.M., and Steitz J.A. HuR and mRNA stability. Cell. Mol. Life Sci. 58 (2001) 266-277
7. Zhang W., Wagner B.J., Ehrenman K., Schaefer A.W., DeMaria C.T., Crater D., DeHaven K., Long L., and Brewer G. Purification characterization and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13 (1993) 7652-7665
8. Carballo E., Lai W.S., and Blackshear P.J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony stimulating factor messenger RNA deadenylation and stability. Blood 95 (2000) 1891-1899
9. Ma W.J., Cheng S., Campbell C., Wright A., and Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271 (1996) 8144-8151
10. Keene J.D. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. USA 96 (1999) 5-7
11. Fan X.C., and Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17 (1998) 3448-3460
12. Peng S.S., Chen C.Y., Xu N., and Shyu A.B. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17 (1998) 3461-3470
13. Levy N.S., Chung S., Furneaux H., and Levy A.P. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273 (1998) 6417-6423
14. Rodriguez-Pascual F., Hausding M., Ihrig-Biedert I., Fumeaux H., Levy A.P., Forstermann U., and Kleinert H. Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding proteins HuR. J. Biol. Chem. 275 (2000) 26040-26049
15. Wang W., Furneaux H., Cheng H., Caldwell M.C., Hutter D., Liu Y., Holbrook N., and Gorospe M. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20 (2000) 760-769
16. Dean J.L., Wait R., Mahtani K.R., Sully G., Clark A.R., and Saklatvala J. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell. Biol. 21 (2001) 721-730
17. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Haynes B.F., and Blackshear P.J. A pathogenic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 (1996) 445-454
18. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Philips R.S., and Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell. Biol. 19 (1999) 4311-4323
19. Lai W.S., and Blackshear P.J. Interactions of CCCH zinc finger protein with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J. Biol. Chem. 276 (2001) 23144-23154
20. Lai W.S., Kennington E.A., and Blackshear P.J. Interaction of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs. J. Biol. Chem. 277 (2002) 9606-9613
21. Chen C.Y., Gherzi R., Ong S.E., Chan E.L., Raijmakers R., Pruijn G.J.M., Stoecklin G., Moroni C., Mann M., and Karin M. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107 (2001) 451-464
22. Mukherjee D., Gao M., O'Connor J.P., Raijmakers R., Pruijn G., Lutz C.S., and Wilusz J. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J. 21 (2002) 165-174
23. Jing Q., Huang S., Guth S., Zarubin T., Motoyama a., Chen J., Padiva F.D., Lin S.-C., Gram H., and Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120 (2005) 623-634
24. Lai W.S., Stumpo D.J., and Blackshear P.J. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J. Biol. Chem. 265 (1990) 16556-16563
25. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281 (1998) 1001-1005
26. Carballo E., Cao H., Lai W.S., Kennington E.A., Campbell D., and Blackshear P.J. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J. Biol. Chem. 276 (2001) 42580-42587
27. Mahtani K.R., Brook M., Dean J.L., Sully G., Saklatvala J., and Clark A.R. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21 (2001) 6461-6479
28. Brook M., Tchen C.R., Santalucia T., McIlrath J., Arthur J.S., Saklatvala J., and Clark A.R. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol. Cell. Biol. 26 (2006) 2408-2418
29. Hitti E., Iakovleva T., Brook M., Deppenmeier S., Gruber A.D., Radzioch D., Clark A.R., Blackshear P.J., Kotlyarov A., and Gaestel M. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26 (2006) 2399-2407
30. Johnson B.A., Stehn J.R., Yaffe M.B., and Blackwell T.K. Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and independent mechanisms. J. Biol. Chem. 277 (2002) 18029-18036
31. Stoecklin G., Stubbs T., Kedersha N., Wax S., FC Rigby W., Blackwell T.K., and Anderson P. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23 (2004) 1313-1324
32. Kracht M., and Saklatvala J. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 20 (2002) 91-106
33. Triantafilou M., and Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23 (2002) 301-304
34. Sakai K., Kitagawa Y., and Hirose G. Binding of neuronal ELAV-like proteins to the uridine-rich sequence in the 3′-untranslated region of tumor necrosis factor-α messenger RNA. FEBS Lett. 446 (1999) 157-162
35. Su B., and Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Biol. 8 (1996) 402-411
36. Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr. Opin. Pharmacol. 4 (2004) 372-377
37. Worthington M.T., Pelo J.W., Sachedina M.A., Applegate J.L., Arseneau K.O., and Pizarro T.T. RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein. J. Biol. Chem. 277 (2002) 48558-48564
38. Rigby W.F.C., Roy K., Collins J., Rigby S., Connolly J.E., Bloch D.B., and Brooks S.A. Structure/function analasis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function. J. Immunol. 174 (2005) 7883-7893
39. Winzen R., Gowrishankar G., Bollog F., Redich N., Resch K., and Holtmann H. Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol. Cell. Biol. 24 (2004) 4835-4847
40. Lal A., Mazan-Mamczarz K., Kawai T., Yang X., Martindale J.L., and Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 23 (2004) 3092-3102
41. Ming X.F., Stoecklin G., Lu M., Looser R., and Moroni C. Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol. Cell. Biol. 21 (2001) 5778-5789
42. Lykke-Andersen J., and Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 19 (2005) 351-361
43. Brooks S.A., Connolly J.E., and Rigby W.F. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent autoregulatory pathway. J. Immunol. 172 (2004) 7264-7271
44. Tchen C.R., Brook M., Saklatvala J., and Clark A.R. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 by tristetraprolin itself. J. Biol. Chem. 279 (2004) 32393-32400
45. Dean J.L., Brook M., Clark A.R., and Saklatvala J. p38 mitogen-activated protein kinase regulates cycloxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274 (1999) 264-269
46. Miyazawa K., Mori A., Miyata H., Akahane M., Ajisawa Y., and Okudaira H. Regulation of interleukin-1 beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 24832-24838
47. Ridley S.H., Dean J.L., Sarsfield S.J., Brook M., Clark A.R., and Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interkin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439 (1998) 75-80
48. Wang S.W., Pawlowski J., Wathen S.T., Kinney S.D., lichenstein H.S., and Manthey C.L. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm. Res. 48 (1999) 533-538
49. Buxade M., Parra J.L., Rousseau S., Shpiro N., Marquez S., Morrice N., Bain J., Espel E., and Proud C.G. The Mnks are novel components in the control of TNFα biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23 (2006) 177-189
50. Rousseau S., Morrice N., Peggie M., Campbell G., Gaestel M., and Cohen P. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J. 21 (2002) 6505-6514